Alberto Azoubel Antunes Antunes *

Autor invitado por SIIC

THIS STUDY HELPS TO ELUCIDATE PROGNOSTIC FACTORS IN BLADDER TRANCICIONAL CELL CARCINOMA

PAPEL DA DIFERENCIAÇÃO ESCAMOSA NO CARCINOMA TRANSICIONAL DA BEXIGA

Squamous differentiation was observed in 25 (22.1%) of the 113 patients. This finding was significantly related only to the pathological stage. Squamous differentiation was an independent prognostic factor for cancer specific survival in patients with bladder cancer treated with radical cystectomy. Further studies with a larger number of patients are necessary to confirm these results.

*Alberto Azoubel Antunes Antunes
describe para SIIC los aspectos relevantes de su trabajo
THE ROLE OF SQUAMOUS DIFFERENTIATION IN PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER TREATED WITH RADICAL CYSTECTOMY
Institución principal de la investigación
*University of Sao Paulo Medical School, São Paulo, Brasil
Imprimir nota

Referencias bibliográficas
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al.: Cancer statistics, 2006. CA Cancer J Clin. 2006; 56: 106-30.
Soloway MS, Lopez AE, Patel J, Lu Y: Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer. 1994; 73: 1926-31.
Sakamoto N, Tsuneyoshi M, Enjoji M: Urinary bladder carcinoma with a neoplastic squamous component: a mapping study of 31 cases. Histopathology. 1992; 21: 135-41.
Budia Alba A, Queipo Zaragoza JA, Perez Ebri ML, Fuster Escriva A, Vera Donoso DC, Vera Sempere FJ, et al.: Comparative study of pure epidermoid carcinoma of the bladder and transitional cell carcinoma with squamous or mixed differentiated foci. Actas Urol Esp. 1999; 23: 111-8.
Mazzucchelli L, Bacchi M, Studer UE, Markwalder R, Sonntag RW, Kraft R: Invasion depth is the most important prognostic factor for transitional-cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapy. Int J Cancer. 1994; 57: 15-20.
Yang MH, Yen CC, Chen PM, Wang WS, Chang YH, Huang WJ, et al.: Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in Taiwan. Urology. 2002; 59: 232-8; discussion 238-9.
Billis A, Schenka AA, Ramos CC, Carneiro LT, Araujo V: Squamous and/or glandular differentiation in urothelial carcinoma: prevalence and significance in transurethral resections of the bladder. Int Urol Nephrol. 2001; 33: 631-3.
Martin JE, Jenkins BJ, Zuk RJ, Blandy JP, Baithun SI: Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J Clin Pathol. 1989; 42: 250-3.
Vecchioli Scaldazza C, Morosetti C: Squamous metaplasia as a prognostic factor in urothelial carcinoma of the bladder. Minerva Urol Nefrol. 1992; 44: 97-100.
Frazier HA, Robertson JE, Dodge RK, Paulson DF: The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer. 1993; 71: 3993-4001.
Sobin LH, Wittekind CH: For the International Union Against Cancer (UICC). Urinary bladder. In TNM Classification of Malignant Tumors. New York, Wiley-Liss. 1997; pp. 187.
Eble J, Sauter G, Epstein J, Sesterhenn I: Pathology and genetics of tumors of urinary system and male genital organs. World Health Organizatoion classification of tumors. Iarc press, Lion. 2004; pp. 93-109.

Otros artículos de Alberto Azoubel Antunes Antunes

1. Antunes AA, Srougi M, Dall'Oglio MF, Crippa A, Nesrallah AJ, Nesrallah LJ, Leite KR. Preoperative determination of prostate cancer tumor volume: analysis through biopsy fragments. Int Braz J Urol. 2007 Jul-Aug;33(4):477-83; discussion 484-5. PMID: 17767751 [PubMed - in process]
2. Antunes AA, Nesrallah LJ, Dall'Oglio MF, Crippa A, Nesrallah AJ, Paranhos M, Leite KR, Srougi M. Perineural invasion by transitional cell carcinoma of the bladder in patients submitted to radical cystectomy: what is the prognostic value? Int Braz J Urol. 2007 Mar-Apr;33(2):161-6. PMID: 17488534 [PubMed - in process]
3. Antunes AA, Srougi M, Coelho RF, de Campos Freire G. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Nat Clin Pract Urol. 2007 Mar;4(3):155-60. Review. PMID: 17347660 [PubMed - indexed for MEDLINE]
4. Antunes AA, Srougi M, Dall'Oglio MF, Crippa A, Paranhos M, Cury J, Nesrallah LJ, Leite KR. Microvascular invasion is an independent prognostic factor in patients with prostate cancer treated with radical prostatectomy. Int Braz J Urol. 2006 Nov-Dec;32(6):668-75; discussion 675-7. PMID: 17201944 [PubMed - indexed for MEDLINE]
5. Antunes AA, Freire Gde C, Aiello Filho D, Cury J, Srougi M. Analysis of the risk factors for incidental carcinoma of the prostate in patients with benign prostatic hyperplasia. Clinics. 2006 Dec;61(6):545-50. PMID: 17187091 [PubMed - indexed for MEDLINE]
6. Antunes AA, Dall'Oglio MF, Barbuto JA, Leite KR, Srougi M. Pure sarcomatous recurrence of clear cell renal carcinoma following radical nephrectomy and dendritic cell vaccination. Sao Paulo Med J. 2006 May 4;124(3):161-2. PMID: 17119695 [PubMed - indexed for MEDLINE]
7. Antunes AA, Crippa A, Dall'Oglio MF, Nesrallah LJ, Leite KR, Srougi M. Age impact in clinicopathologic presentation and the clinical evolution of prostate cancer in patients submitted to radical prostatectomy. Int Braz J Urol. 2006 Jan-Feb;32(1):48-55. PMID: 16519828 [PubMed - indexed for MEDLINE]
8. Antunes AA, Nesrallah LJ, Dall'Oglio MF, Ferreira YA, Passerotti CC, Leite KR, Ortiz V, Srougi M. Analysis of prognostic factors in patients with transitional cell carcinoma of the bladder treated with radical cystectomy. Int Braz J Urol. 2006 Jan-Feb;32(1):35-42. PMID: 16519826 [PubMed - indexed for MEDLINE]
9. Antunes AA, Srougi M, Dall'Oglio MF, Crippa A, Campagnari JC, Leite KR. The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy. BJU Int. 2005 Dec;96(9):1258-63. PMID: 16287441 [PubMed - indexed for MEDLINE]
10. Antunes AA, Leite KR, Dall'Oglio MF, Crippa A, Nesrallah LJ, Srougi M. Prostate biopsy: is age important for determining the pathological features in prostate cancer? Int Braz J Urol. 2005 Jul-Aug;31(4):331-7. PMID: 16137401 [PubMed - indexed for MEDLINE]

Para comunicarse con Alberto Azoubel Antunes Antunes mencionar a SIIC como referencia:
antunesuro@uol.com.br

---

Acerca del trabajo completo

PAPEL DA DIFERENCIAÇÃO ESCAMOSA NO CARCINOMA TRANSICIONAL DA BEXIGA

Título original en portugués
O PAPEL DA DIFERENCIAÇÃO ESCAMOSA NOS PACIENTES COM CARCINOMA TRANSICIONAL DA BEXIGA TRATADO COM DISTECTOMIA RADICAL

Autor
Alberto Azoubel Antunes Antunes¹, Miguel Srougi²
1 Doctor, University of Sao Paulo Medical School, São Paulo, Brasil, Urologist
2 Doctor, University of Sao Paulo Medical School, São Paulo, Brasil, Chairman

Acceso a la fuente original
International Brazilian Journal of Urology
http://www.brazjurol.com.br/

El artículo se relaciona estrictamente con las especialidades de siicsalud
El artículo se conecta secundariamente con las especialidades